Radiographic and Clinical Factors in Pediatric Patients With Surgical Small-bowel Intussusception

Robert J Vandewalle1, Alexis K Bagwell1, Jared R Shields2

  • 1Division of Pediatric Surgery, Department of General Surgery, Indiana University School of Medicine, Indianapolis, Indiana.

Insights

Small bowel-to-small bowel intussusception (SBI) in children presents a diagnostic challenge. Focal abdominal pain, prior surgery, and intussusception length predict the need for surgical intervention in SBI cases.

Area of Science:

  • Pediatric Surgery
  • Abdominal Imaging
  • Gastrointestinal Radiology

Background:

  • Small bowel-to-small bowel intussusception (SBI) in pediatric patients poses a diagnostic dilemma.
  • The clinical significance and surgical necessity of SBI are highly variable.
  • Most SBIs are considered clinically insignificant, complicating operative decisions.

Purpose of the Study:

  • To identify clinical and radiologic factors guiding operative decisions in pediatric patients with SBI.
  • To differentiate between clinically significant and insignificant SBIs.
  • To aid clinicians in managing pediatric abdominal pain cases involving SBI.

Main Methods:

  • Retrospective review of a pediatric tertiary hospital database (2011-2016).
  • Inclusion of patients with radiologic evidence of SBI only (excluding ileocolic intussusception).
  • Analysis of clinical presentation, operative intervention, and surgical findings; exclusion of SBI due to feeding tubes.

Main Results:

  • 139 pediatric patients with SBI were identified.
  • Multivariate analysis revealed key predictors for surgical intervention.
  • Significant predictors included prior abdominal surgery (OR: 7.2), focal abdominal pain (OR: 22.1), and intussusception length (OR: 10.6).

Conclusions:

  • Small bowel-to-small bowel intussusception (SBI) exhibits variable clinical significance.
  • Focal abdominal pain, prior abdominal surgery, and intussusception length are primary predictors for operative intervention in SBI.
  • These factors can guide surgical decision-making in pediatric SBI cases.
Abstract

Related Concept Videos

Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
521
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
261
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
307
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
227
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
298
Factors Affecting Protein-Drug Binding: Patient-Related Factors01:29

Factors Affecting Protein-Drug Binding: Patient-Related Factors

Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
324